Trials / Completed
CompletedNCT01214200
High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)
High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV) for Stable Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Philips Respironics · Industry
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to evaluate the effect of high intensity non-invasive positive pressure ventilation (HINPPV) for stable, hypercapnic COPD patients. The investigators believe that HINPPV, used at least 6 hours nocturnally over three months, will benefit the stable hypercapnic COPD patient through a reduction in the daytime partial pressure of carbon dioxide in arterial blood (PaCO2) levels.
Detailed description
The High Intensity Non-invasive Positive Pressure trial is a single arm interventional study. The purpose of this study is to evaluate the effect of High Intensity Non-invasive ventilation (HINPPV) in stable Chronic Obstructive Pulmonary patients with chronically elevated carbon dioxide levels. Participants will undergo various testing ( arterial blood gas (ABG), Pulmonary Function Test (PFTs), Polysomnography (PSGs), 6 minute walk tests)over a 3 month period to determine if this type of therapy will improve daytime carbon dioxide levels. The participants will also complete quality of life questionnaires to help ascertain improvements in their daily living activities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bilevel positive airway pressure (BiPAP) | This is a single arm interventional study. Hypercapnic COPD participants that meet eligibility criteria will receive high intensity non-invasive positive pressure ventilation(HINPPV). Participants will receive HINPPV via bilevel positive airway pressure (BiPAP) via a Synchrony ventilator if they require an inspiratory positive airway pressure (IPAP) less than or equal to 30 cmH2O; or the Trilogy ventilator if they require an IPAP greater than 30 cmH2O. |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2010-10-04
- Last updated
- 2019-01-02
- Results posted
- 2019-01-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01214200. Inclusion in this directory is not an endorsement.